Senescence in chronic allograft nephropathy.
Despite increasing numbers of patients on dialysis, the numbers of renal transplants performed yearly have remained relatively static. During the last 50 years, there have been many advances in the pharmacology of prevention of organ rejection. However, most patients will suffer from a slow but steady decline in renal function leading to graft loss. The most common cause of long-term graft loss is chronic allograft nephropathy (CAN). Therefore, elucidating and understanding the mechanisms involved in CAN is crucial for achieving better posttransplant outcomes. It is thought that the development of epithelial to mesenchymal transition (EMT) in proximal tubules is one of the first steps towards CAN, and has been shown to be a result of cellular senescence. Cells undergoing senescence acquire a senescence associated secretory phenotype (SASP) leading to the production of interleukin-1 alpha (IL-1α), which has been implicated in several degenerative and inflammatory processes including renal disease. A central mediator in SASP activation is the production of reactive oxygen species (ROS), which are produced in response to numerous physiological and pathological stimuli. This review explores the connection between SASP and the development of EMT/CAN in an effort to suggest future directions for research leading to improved long-term graft outcomes.
SUNY Polytechnic Institute, Colleges of Nanoscale Science and Engineering, Albany, New York.
María Del Pilar
MDP
Sosa Peña
Albany Medical Center, Department of Surgery, Division of Transplantation, Albany, New York.
Reynold
R
Lopez-Soler
SUNY Polytechnic Institute, Colleges of Nanoscale Science and Engineering, Albany, New York.
J Andrés
JA
Melendez
D002908:Chronic Disease; D058750:Epithelial-Mesenchymal Transition / Q000276:immunology / Q000502:physiology*; D006084:Graft Rejection / Q000209:etiology*; D006801:Humans; D016030:Kidney Transplantation / Q000379:methods; D013995:Time; D014184:Transplantation, Homologous / Q000009:adverse effects
fibrosis; kidney transplant; transplant rejection